Neursantys
PrivateLast Round
Grant
Jul 27, 2024
Est. Valuation
$3.12M
Total Funding Raised
$842,500
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Neursantys is a medical devices company developing non-invasive bioelectronic devices and treatments to address neuromotor conditions caused by aging, trauma, or disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neursantys Comparables
Compare Neursantys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RxFunction | 80% | |
| Bioness Medical, Inc. | 78% | |
| GaitBetter | 74% |
Neursantys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 27, 2024 | ||||
| Grant | Jun 12, 2024 | ||||
| Accelerator | Oct 1, 2023 | ||||
| Grant | Apr 28, 2023 | ||||
| Seed | Mar 14, 2023 | ||||
Grant | Jun 30, 2022 |
Neursantys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| a2 Collective | Grant |
| AgeTech Collaborative | Grant |
| mHUB Ventures | Seed, Accelerator |
| National Institute on Aging | Grant |
| National Institute on Aging | Grant |
| Canadian Space Agency | Grant |
| Edward-Elmhurst Health Venture Capital | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 36% MoM.
- Jun 18, 2026
Monthly visitors grew 611% MoM, reaching 1K.
Neursantys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neursantys's valuation, stock price, and market status.
Is Neursantys a public or private company?
Neursantys is a private company.
What is the current stock price of Neursantys?
Neursantys is a private company with no public stock price. No recent secondary market data is available.
How much is Neursantys worth (valuation)?
Neursantys's valuation is estimated at $3.1M based on funding round data.
Can I buy Neursantys stock?
Neursantys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neursantys's last funding round?
Neursantys's most recent funding round was Grant on November 10, 2021.
Who are the main investors in Neursantys?
Key investors in Neursantys include mHUB Ventures.
Will Neursantys IPO soon?
No public IPO plans have been announced for Neursantys.
How can I track Neursantys secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neursantys's secondary market activity and sign up for updates.